The HER2 morphometric signature is characterised by larger nuclear and cellular areas, increased nuclear size variability and wider inter‐nuclear spacing, reflecting an aggressive tumour phenotype associated with high HER2 activity. This evidence concerns the gene ERBB2 and neoplasm.